Lysol maker Reckitt Benckiser sees profits slump on lower sales, Middle East accounting issue

Lysol seller Reckitt Benckiser Group on Wednesday posted a sharp drop in its profits for the full-year 2023, as higher prices failed to offset lower sales, in a “grim” set of results that put the company on course for its sharpest share price drop in years.The Durex owner said lower sales of cold and flu medicines and its decision to recall batches of its Nutramigen baby formula saw its operating profits drop 22.1% to £2.53 billion ($3.2 billion) and company CEO Kris Licht call